%D9%88%D8%B1%D8%A7%D9%85_%D8%B9%D8%B6%D9%84%D9%8A_%D8%A3%D9%85%D9%84%D8%B3_%D9%88%D8%B9%D8%A7%D8%A6%D9%8A_%D9%84%D9%85%D9%81%D9%8ACategory:LymphangioleiomyomatosisLymphangioleiomyomatoseLymphangioleiomyomatosisLymphangiol%C3%A9iomyomatoseLinfangioleiomiomatosi%E3%83%AA%E3%83%B3%E3%83%91%E8%84%88%E7%AE%A1%E7%AD%8B%E8%85%AB%E7%97%87LymfangioleiomyomatoseLimfangioleiomiomatozaLinfangioleiomiomatose%D0%9B%D0%B8%D0%BC%D1%84%D0%B0%D0%BD%D0%B3%D0%B8%D0%BE%D0%BB%D0%B5%D0%B9%D0%BE%D0%BC%D0%B8%D0%BE%D0%BC%D0%B0%D1%82%D0%BE%D0%B7Lenfanjiyoleyomiyomatozis%D8%B3%DB%8C%D8%A7%D9%84%DB%81_%D9%88%D8%B9%D8%A7%D8%A6%DB%8C_%DB%81%D9%85%D8%B9%D8%B6%D9%84%D9%88%D9%85%DB%81Q1878759%E6%B7%8B%E5%B7%B4%E7%AE%A1%E5%B9%B3%E6%BB%91%E8%82%8C%E5%A2%9E%E7%94%9F
about
sameAs
Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAMRole of Helicobacter Pylori and Its Toxins in Lung and Digestive System DiseasesA Study of Nintedanib for LymphAngioleioMyomatosis (LAM)Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign DiseaseTrial of Aromatase Inhibition in LymphangioleiomyomatosisDiscovery of Sirolimus Sensitive Biomarkers in BloodStudy of the Disease Process of LymphangioleiomyomatosisLAM Pilot Study With Imatinib MesylateSafety of Simvastatin in LAM and TSCPulmonary Rehabilitation in LymphangioleiomyomatosisSafety and Durability of Sirolimus for Treatment of LAMLymphatic Anomalies RegistrySafety Study of Sirolimus and Hydroxychloroquine in Women With LymphangioleiomyomatosisNational Lymphangioleiomyomatosis Registry, FranceA Study to Determine the Effectiveness of Escalating Doses of RAD001 (Everolimus) in Patients With LymphangioleiomyomatosisPulmonary Hypertension in LymphangioleiomyomatosisLong Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and AngiomyolipomaThe Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)Nebulized or Inhaled Albuterol for LymphangioleiomyomatosisDoxycycline In Lymphangioleiomyomatosis (LAM)Effect of Fasting on the Size of Abdominal Lymphatic Tumors in WomenEfficacy and Safety of Sirolimus for Treating Lymphangioleiomyomatosis (LAM)RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAMRapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAMA National Registry on Chinese Patients With LymphangioleiomyomatosisMulticenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease TrialTreatment With Octreotide in Patients With LymphangioleiomyomatosisLymphangioleiomyomatosis (LAM) RegistryOfficial Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM)Resveratrol and Sirolimus in Lymphangioleiomyomatosis TrialThe Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation PatientsSafety and Efficacy of Saracatinib In Subjects With LymphangioleiomyomatosisCOLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSCBenefits of Pulmonary Rehabilitation in Patients With Severe Lymphangioleiomyomatosis (LAM)Glutamine PET Imaging in LAM
P1050
P2175
Q61918025-125E2740-D56A-4997-A022-3F34F96ECBE5Q61934099-1C1CE0D0-DCCB-46E1-81DA-6378C0CE3DAEQ63229737-88002221-2706-49AF-AAE0-AB36A3AE75DCQ63319547-50A0290F-0AAC-4FB2-98B4-2433D20A8A75Q63333963-C5AC7ED0-A428-4063-9D20-73434BA5AF04Q63811502-44977A23-0FAC-485C-89F7-88D80099D91AQ64171048-48E15DAC-6783-40AA-A52B-72E0B153FC11Q64172185-9FD8CDD1-C3EC-4B32-949B-00433C52AA2BQ64335410-6FB9BA8B-E2D5-4A21-AE6F-4CE4D5E96B12Q64351246-B1A5965F-435C-4615-A681-A08559BCED0AQ64393454-03D6AA7A-196D-49AF-9685-287F6ECC9366Q64394872-B19DF86E-C9C9-48EA-A7A6-310579FE56E4Q64641326-4D198474-FA0F-4107-BA2D-680D211B6B50Q64647086-2039DA92-0F30-4EBE-9220-2A2A65B10E5CQ64656129-AE167A64-5E81-464F-A5FB-1B2450FD3E63Q64663759-B0882945-3144-4493-B779-5A5D4E0C9185Q64709713-17769AFA-0CB7-48B0-B76D-3B4CCD1A0F49Q64709911-550AF24D-227D-4464-BD36-688C1F631247Q65352852-7D003ED5-4FF4-4B4B-A03A-751C90252C47Q65357418-71E7A372-A30F-4557-9DA4-74E6923DE651Q65368829-91B10389-DAA9-4920-A56C-B745617AFD9DQ65377068-447479A3-7884-436C-B4EA-C71B90075684Q65380976-99F0717C-433C-484C-A7DB-2B15DB43720FQ65384738-60950D78-5764-4112-A9C5-A26484A03058Q65384811-598310CA-1296-4DCE-876F-99680F3A2461Q65384835-3C4EBE40-F58A-48CB-A28D-61F1D672BF0BQ66043303-8A71FB5D-3695-4D2B-9C1A-5468F033A0F3Q66044286-6E0E0B2B-18BE-4B07-A8BD-3909B2CD55A9Q66060107-95DBEDB3-9A2A-49B2-8070-CCD95759FCB2Q66060261-1F107BF2-A09F-41B6-A069-008E41AAB246Q66060946-EB0C947A-8FD8-4EBA-97F7-69FF302DADE3Q66067630-488E3697-911D-4757-A0A4-6BE8B29A359DQ66395081-5FCF3E61-362F-4B56-9214-0BC2001D418EQ66405943-8DA22763-4112-4A03-9008-7A1272682F02Q67127489-FB05ECAA-BF03-49DB-9263-3D9BC25F43FDQ79111562-89EF68F4-08BD-4977-83EF-45E910E2586FQ94486214-83B05D6B-0D0D-4BB8-A468-6AEC663D080C
P1050
description
Krankheit
@de
choroba
@pl
human disease
@en
malattia dell'apparato respiratorio
@it
مرض يصيب الإنسان
@ar
name
Lenfanjiyoleyomiyomatozis
@tr
Limfangioleiomiomatoza
@pl
Lymphangioleiomyomatose
@de
linfangioleiomiomatose
@pt
linfangioleiomiomatosi
@it
linfangioleiomiomatosis
@es
lymfangioleiomyomatose
@nl
lymphangioleiomyomatosis
@en
lymphangioléiomyomatose
@fr
Лимфангиолейомиоматоз
@ru
type
label
Lenfanjiyoleyomiyomatozis
@tr
Limfangioleiomiomatoza
@pl
Lymphangioleiomyomatose
@de
linfangioleiomiomatose
@pt
linfangioleiomiomatosi
@it
linfangioleiomiomatosis
@es
lymfangioleiomyomatose
@nl
lymphangioleiomyomatosis
@en
lymphangioléiomyomatose
@fr
Лимфангиолейомиоматоз
@ru
altLabel
LAM
@en
LAM
@pl
LAM
@ur
LYMPHANGIOLEIOMYOMATOSIS; LAM
@en
Lung Lymphangiomyomatosis
@en
Lymphangio-myomatosis
@en
Lymphangioleiomyomatose
@fr
Lymphangioleiomyomatosis
@en
Lymphangioleiomyomatosis
@ur
Lymphangioleiomyomatosis; LAM
@en
prefLabel
Lenfanjiyoleyomiyomatozis
@tr
Limfangioleiomiomatoza
@pl
Lymphangioleiomyomatose
@de
linfangioleiomiomatose
@pt
linfangioleiomiomatosi
@it
linfangioleiomiomatosis
@es
lymfangioleiomyomatose
@nl
lymphangioleiomyomatosis
@en
lymphangioléiomyomatose
@fr
Лимфангиолейомиоматоз
@ru